Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insperity, Inc. Common Stock
(NY:
NSP
)
54.03
+0.85 (+1.60%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insperity, Inc. Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Insperity Announces Third Quarter Results
October 31, 2023
From
Insperity, Inc.
Via
Business Wire
Earnings Scheduled For October 31, 2023
↗
October 31, 2023
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of...
Via
Benzinga
Preview: Insperity's Earnings
↗
October 30, 2023
Via
Benzinga
Insperity's Ex-Dividend Date Is Thursday, Here's What You Need To Know
↗
September 04, 2023
Via
Benzinga
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
↗
October 21, 2023
These two businesses are masterful at reinvesting in their operations.
Via
The Motley Fool
Insperity Third Quarter Earnings Conference Call Tuesday, October 31
October 20, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Declares Quarterly Dividend of $0.57
August 24, 2023
From
Insperity, Inc.
Via
Business Wire
Analyst Expectations for Insperity's Future
↗
June 15, 2023
Via
Benzinga
Insperity Increases Dividend By 10%
↗
May 24, 2023
Via
Benzinga
Insperity Earnings Perspective: Return On Capital Employed
↗
April 28, 2023
Via
Benzinga
3 Top Stocks to Buy for the Long Haul
↗
August 02, 2023
These three businesses, which are yet to join the market's rally in 2023, could be brilliant buy-and-hold investments when looking a decade ahead.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
↗
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session
↗
August 01, 2023
Via
Benzinga
Looking Into Insperity's Return On Capital Employed
↗
February 13, 2023
Via
Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
↗
August 01, 2023
Via
Benzinga
Insperity Announces Second Quarter Results
August 01, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Second Quarter Earnings Conference Call Tuesday, August 1
July 21, 2023
From
Insperity, Inc.
Via
Business Wire
3 Stocks That Smart Investors Should Be Flocking to Now
↗
May 30, 2023
Investors may want to detour away from the obvious trades and consider compelling top stocks for smart investors.
Via
InvestorPlace
Insperity Raises Quarterly Dividend by 10%
May 24, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Announces First Quarter Results
April 26, 2023
From
Insperity, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
↗
April 24, 2023
Via
Benzinga
Insperity First Quarter Earnings Conference Call Wednesday, April 26
April 14, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Declares Quarterly Dividend of $0.52
February 24, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Announces Record Fourth Quarter and Full Year 2022 Results
February 09, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Fourth Quarter Earnings Conference Call Thursday, February 9
January 30, 2023
From
Insperity, Inc.
Via
Business Wire
Earnings Scheduled For February 9, 2023
↗
February 09, 2023
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
Via
Benzinga
Insperity Honored as One of the Best Places to Work in 2023, a Glassdoor Employees’ Choice Award Winner
January 18, 2023
From
Insperity, Inc.
Via
Business Wire
Insperity Declares Quarterly Dividend of $0.52
November 18, 2022
From
Insperity, Inc.
Via
Business Wire
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
↗
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
